Park Place Capital’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $28.6K | Sell |
185
-24
| -11% | -$3.71K | 0.01% | 429 |
|
|
2025
Q1 | $31.5K | Hold |
209
| – | – | 0.01% | 396 |
|
|
2024
Q4 | $38.6K | Sell |
209
-264
| -56% | -$48.7K | 0.01% | 388 |
|
|
2024
Q3 | $93.2K | Sell |
473
-5
| -1% | -$985 | 0.03% | 293 |
|
|
2024
Q2 | $98.7K | Sell |
478
-52
| -10% | -$10.7K | 0.03% | 278 |
|
|
2024
Q1 | $144K | Buy |
530
+14
| +3% | +$3.79K | 0.05% | 272 |
|
|
2023
Q4 | $122K | Sell |
516
-337
| -40% | -$79.7K | 0.05% | 278 |
|
|
2023
Q3 | $167K | Sell |
853
-8
| -0.9% | -$1.57K | 0.05% | 260 |
|
|
2023
Q2 | $181K | Buy |
861
+16
| +2% | +$3.36K | 0.05% | 258 |
|
|
2023
Q1 | $171K | Buy |
845
+28
| +3% | +$5.65K | 0.05% | 264 |
|
|
2022
Q4 | $178K | Buy |
+817
| New | +$178K | 0.05% | 256 |
|